MindBio Therapeutics (XCNQ:MBIO) Pretax Margin % : 17.71% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. MindBio Therapeutics's Pre-Tax Income for the three months ended in Mar. 2024 was C$0.07 Mil. MindBio Therapeutics's Revenue for the three months ended in Mar. 2024 was C$0.38 Mil. Therefore, MindBio Therapeutics's pretax margin for the quarter that ended in Mar. 2024 was 17.71%.

The historical rank and industry rank for MindBio Therapeutics's Pretax Margin % or its related term are showing as below:

XCNQ:MBIO' s Pretax Margin % Range Over the Past 10 Years
Min: -563.82 Med: 0 Max: 0
Current: -563.82

XCNQ:MBIO's Pretax Margin % is ranked worse than
66.31% of 1027 companies
in the Biotechnology industry
Industry Median: -155.67 vs XCNQ:MBIO: -563.82

MindBio Therapeutics Pretax Margin % Historical Data

The historical data trend for MindBio Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Pretax Margin % Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Pretax Margin %

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pretax Margin %	Get a 7-Day Free Trial					-	-	-	-20.34	17.71

Competitive Comparison of MindBio Therapeutics's Pretax Margin %

For the Biotechnology subindustry, MindBio Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MindBio Therapeutics's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindBio Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where MindBio Therapeutics's Pretax Margin % falls into.

MindBio Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

MindBio Therapeutics's Pretax Margin for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-3.823	/	0
	=	%

MindBio Therapeutics's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0.068	/	0.384
	=	17.71 %

MindBio Therapeutics (XCNQ:MBIO) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

MindBio Therapeutics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.